Retraction: A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation (PLoS ONE (2011) 6 9 (e25295) DOI: 10.1371/journal.pone.0025295);A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBV-associated hepatocellular carcinoma after liver transplantation

PLoS ONE

Volumn 6, Issue 9, 2011, Pages

  Wang, Guo Ying ^a   Yang, Yang ^a   Li, Hua ^a   Zhang, Jian ^a   Jiang, Nan ^a   Li, Min Ru ^a   Zhu, Huan Bing ^a   Zhang, Qi ^b   Chen, Gui Hua ^a,b  

^a SUN YAT SEN UNIVERSITY   (China)

^b Guangdong Provincial Key Laboratory of Liver Disease Research   (China)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; CANCER INVASION; CANCER RECURRENCE; CANCER RISK; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE FREE SURVIVAL; FEMALE; HEPATITIS B; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; NEUTROPHIL COUNT; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT CODING; PREDICTION; PROGNOSIS; RISK FACTOR; SCORING SYSTEM; SURVIVAL RATE; SURVIVAL TIME; TUMOR VOLUME; CYTOLOGY; HEPATITIS B VIRUS; IMMUNOLOGY; KAPLAN MEIER METHOD; LIVER TUMOR; LYMPHOCYTE; MIDDLE AGED; NEUTROPHIL; PATHOGENICITY; PROPORTIONAL HAZARDS MODEL; TUMOR RECURRENCE; VIROLOGY;

HEPATITIS B VIRUS;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATITIS B VIRUS; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LIVER TRANSPLANTATION; LYMPHOCYTES; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUTROPHILS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS;

EID: 80053140517     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0220418     Document Type: Erratum

References (42)

1. Chen GH, (2009) Liver transplantation in China: retrospect and prospect. Chin Med J (Engl) 122: 2229-30.
2. Mazzaferro V, Regalia E, Doci R, Andreola S, Pulvirenti A, et al. (1996) Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 334: 693-9.
3. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, et al. (2001) Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 33: 1394-403.
4. Cillo U, Vitale A, Bassanello M, Boccagni P, Brolese A, et al. (2004) Liver transplantation for the treatment of moderately or well-differentiated hepatocellular carcinoma. Ann Surg 239: 150-9.
5. Rahbari NN, Mehrabi A, Mollberg NM, Muller SA, Koch M, et al. (2011) Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 253: 453-69.
6. Ishizaki Y, Kawasaki S, (2008) The evolution of liver transplantation for hepatocellular carcinoma (past, present, and future). J Gastroenterol 43: 18-26.
7. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, et al. (2009) Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 10: 35-43.
8. Silva M, Moya A, Berenguer M, Sanjuan F, Lopez-Andujar R, et al. (2008) Expanded criteria for liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Liver Transpl 14: 1449-60.
9. Herrero JI, Sangro B, Pardo F, Quiroga J, Inarrairaegui M, et al. (2008) Liver transplantation in patients with hepatocellular carcinoma across Milan criteria. Liver Transpl 14: 272-8.
10. Freeman RB, Mithoefer A, Ruthazer R, Nguyen K, Schore A, et al. (2006) Optimizing staging for hepatocellular carcinoma before liver transplantation: a retrospective analysis of the UNOS/OPTN database. Liver transplantation 12: 1504-11.
11. Jonas S, Bechstein WO, Steinmuller T, Herrmann M, Radke C, et al. (2001) Vascular invasion and histopathologic grading determine outcome after liver transplantation for hepatocellular carcinoma in cirrhosis. Hepatology 33: 1080-6.
12. Coussens LM, Werb Z, (2002) Inflammation and cancer. Nature 420: 860-7.
13. Grivennikov SI, Greten FR, Karin M, (2010) Immunity, inflammation, and cancer. Cell 140: 883-99.
14. Hashimoto K, Ikeda Y, Korenaga D, Tanoue K, Hamatake M, et al. (2005) The impact of preoperative serum C-reactive protein on the prognosis of patients with hepatocellular carcinoma. Cancer 103: 1856-64.
15. Halazun KJ, Aldoori A, Malik HZ, Al-Mukhtar A, Prasad KR, et al. (2008) Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases. Eur J Surg Oncol 34: 55-60.
16. Malik HZ, Prasad KR, Halazun KJ, Aldoori A, Al-Mukhtar A, et al. (2007) Preoperative prognostic score for predicting survival after hepatic resection for colorectal liver metastases. Ann Surg 246: 806-14.
17. Gomez D, Farid S, Malik HZ, Young AL, Toogood GJ, et al. (2008) Preoperative neutrophil-to-lymphocyte ratio as a prognostic predictor after curative resection for hepatocellular carcinoma. World J Surg 32: 1757-62.
18. Halazun KJ, Hardy MA, Rana AA, Woodland DCt, Luyten EJ, et al. (2009) Negative impact of neutrophil-lymphocyte ratio on outcome after liver transplantation for hepatocellular carcinoma. Ann Surg 250: 141-51.
19. Bertuzzo VR, Cescon M, Ravaioli M, Grazi GL, Ercolani G, et al. Analysis of factors affecting recurrence of hepatocellular carcinoma after liver transplantation with a special focus on inflammation markers. Transplantation 91: 1279-85.
20. Zheng SS, Xu X, Wu J, Chen J, Wang WL, et al. (2008) Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 85: 1726-32.
21. Aggarwal BB, Vijayalekshmi RV, Sung B, (2009) Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res 15: 425-30.
22. Sharaiha RZ, Halazun KJ, Mirza F, Port JL, Lee PC, et al. (2011) Elevated Preoperative Neutrophil:Lymphocyte Ratio as a Predictor of Postoperative Disease Recurrence in Esophageal Cancer. Ann Surg Oncol.
23. Ubukata H, Motohashi G, Tabuchi T, Nagata H, Konishi S, (2010) Evaluations of interferon-gamma/interleukin-4 ratio and neutrophil/lymphocyte ratio as prognostic indicators in gastric cancer patients. J Surg Oncol 102: 742-7.
24. Shimada H, Takiguchi N, Kainuma O, Soda H, Ikeda A, et al. (2010) High preoperative neutrophil-lymphocyte ratio predicts poor survival in patients with gastric cancer. Gastric Cancer 13: 170-6.
25. Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ, (2005) Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 91: 181-4.
26. Chua W, Charles KA, Baracos VE, Clarke SJ, (2011) Neutrophil/lymphocyte ratio predicts chemotherapy outcomes in patients with advanced colorectal cancer. Br J Cancer 104: 1288-95.
27. Kishi Y, Kopetz S, Chun YS, Palavecino M, Abdalla EK, et al. (2009) Blood neutrophil-to-lymphocyte ratio predicts survival in patients with colorectal liver metastases treated with systemic chemotherapy. Ann Surg Oncol 16: 614-22.
28. Garcea G, Ladwa N, Neal C, Metcalfe M, Dennison A, et al. (2011) Preoperative Neutrophil-to-Lymphocyte Ratio (NLR) is Associated with Reduced Disease-free Survival Following Curative Resection of Pancreatic Adenocarcinoma. World J Surg 35: 1-5.
29. Gomez D, Morris-Stiff G, Toogood GJ, Lodge JP, Prasad KR, (2008) Impact of systemic inflammation on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 97: 513-8.
30. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, et al. (2008) High expression of macrophage colony-stimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 26: 2707-16.
31. Amano H, Itamoto T, Emoto K, Hino H, Asahara T, et al. (2005) Granulocyte colony-stimulating factor-producing combined hepatocellular/cholangiocellular carcinoma with sarcomatous change. J Gastroenterol 40: 1158-9.
32. Araki K, Kishihara F, Takahashi K, Matsumata T, Shimura T, et al. (2007) Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int 27: 716-21.
33. Yu D, Sun X, Qiu Y, Zhou J, Wu Y, et al. (2007) Identification and clinical significance of mobilized endothelial progenitor cells in tumor vasculogenesis of hepatocellular carcinoma. Clin Cancer Res 13: 3814-24.
34. Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, et al. (2006) Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol 45: 246-53.
35. Kim HS, Han KH, Chung HH, Kim JW, Park NH, et al. (2010) Neutrophil to lymphocyte ratio for preoperative diagnosis of uterine sarcomas: a case-matched comparison. Eur J Surg Oncol 36: 691-8.
36. Sumie S, Kuromatsu R, Okuda K, Ando E, Takata A, et al. (2008) Microvascular invasion in patients with hepatocellular carcinoma and its predictable clinicopathological factors. Ann Surg Oncol 15: 1375-82.
37. Vibert E, Azoulay D, Hoti E, Iacopinelli S, Samuel D, et al. (2010) Progression of alphafetoprotein before liver transplantation for hepatocellular carcinoma in cirrhotic patients: a critical factor. Am J Transplant 10: 129-37.
38. Duffy JP, Vardanian A, Benjamin E, Watson M, Farmer DG, et al. (2007) Liver transplantation criteria for hepatocellular carcinoma should be expanded: a 22-year experience with 467 patients at UCLA. Ann Surg 246: 502-9; discussion 9-11.
39. Lohe F, Angele MK, Rentsch M, Graeb C, Gerbes A, et al. (2007) Multifocal manifestation does not affect vascular invasion of hepatocellular carcinoma: implications for patient selection in liver transplantation. Clin Transplant 21: 696-701.
40. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM, (2009) Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 49: 832-8.
41. McCormack L, Petrowsky H, Clavien PA, (2005) Surgical therapy of hepatocellular carcinoma. Eur J Gastroenterol Hepatol 17: 497-503.
42. Mohri Y, Tanaka K, Ohi M, Yokoe T, Miki C, et al. (2010) Prognostic significance of host- and tumor-related factors in patients with gastric cancer. World J Surg 34: 285-90.